The current financial score of Medpace Holdings Inc is 8.69. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 716.00M, representing a year-over-year increase of 8.50%, while its net profit experienced a year-over-year increase of 23.69%.
The current valuation score of Medpace Holdings Inc is 9.89. Its current P/E ratio is 40.19, which is 11.79% below the recent high of 44.93 and 48.94% above the recent low of 20.52.
The current earnings forecast score of Medpace Holdings Inc is 6.29. The average price target is 651.91, with a high of 730.00 and a low of 377.81.
The current price momentum score of Medpace Holdings Inc is 3.78. Currently, the stock price is trading between the resistance level at 700.50 and the support level at 596.99, making it suitable for range-bound swing trading.
The current institutional shareholding score of Medpace Holdings Inc is 7.00. The latest institutional shareholding proportion is 85.88%, representing a quarter-over-quarter decrease of 1.23%.
The current risk assessment score of Medpace Holdings Inc is 7.04. The company's beta value is 1.19. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.